Inspiration Healthcare Group PLC Notice of Results, Mello and AIM Awards (8133M)

TIDMIHC

RNS Number : 8133M

Inspiration Healthcare Group PLC

24 September 2021

Inspiration Healthcare Group plc

("Inspiration Healthcare", the "Company" or the "Group")

Notice of Results, Mello presentation and Shortlisting for AIM Award

Inspiration Healthcare Group plc (AIM: IHC), the global medical technology company , will announce its unaudited interim results for the six months ended 31 July 2021 on Tuesday, 5 October 2021.

Results presentation

Neil Campbell, Chief Executive Officer and Jon Ballard, Chief Financial Officer will host an investor presentation on the 5 October 2021 at 9.30 am in London and details on how to attend can be obtained from Alex Walters at Cadogan PR at [e-mail]

Mello presentation

Neil Campbell will also be presenting at the Mello Investor evening on Monday 11 October which is taking place online between 4pm to 8pm and will give a summary of the results as well taking questions from participants. Investors and interested parties can register for the event at: https://melloevents.com/mellomonday-11th-october/ using code SHVIP for 75% off tickets.

Entrepreneur of the Year Award

Inspiration Healthcare is also delighted to announce that Chief Executive Officer, Neil Campbell has been shortlisted for the "Entrepreneur of the Year" award at the 2021 AIM Awards organised by the London Stock Exchange in conjunction with lead sponsors BDO. The winner will be announced at the Awards dinner on Thursday 14 October 2021.

Enquiries:

 
 Inspiration Healthcare Group plc          Tel: [phone] 
  Neil Campbell, Chief Executive Officer 
  Jon Ballard, Chief Financial Officer 
 Nominated Adviser & Broker                Tel: [phone] 
  Cenkos Securities plc 
  Mark Connelly 
  Stephen Keys 
 Cadogan PR                                Tel: [phone] 
  Alex Walters 
  [e-mail] 
 

About Inspiration Healthcare Group

www.inspirationhealthcaregroup.plc.uk

Inspiration Healthcare (AIM: IHC) is a global provider of medical technology for use in critical care & operating theatres. The Company provides high-quality, innovative products to patients around the world which help to improve patient outcomes, and it actively invests in innovative product opportunities and disruptive technologies.

The Group currently consists of three companies: Inspiration Healthcare Ltd, SLE Ltd and Viomedex Ltd and under these brands the Group sells neonatal intensive care and operating theatre equipment around the work through a network of distributors into over 75 countries. Products range from highly sophisticated capital equipment through to single use disposables all that can help improve outcomes of extremely sick patients.

In the UK and Ireland the Group offers direct sales for most of its products supported by Technical Service offering on site and return to base repair and maintenance along with 24/7 emergency hire of equipment and long term lease arrangements for its own brand products. The Group also acts as a distributor for 3(rd) party companies that wish to access the NHS using the Group's sales and service expertise and knowledge of the NHS

The Group invests in growth through Research and Development holding numerous patents on its technology and has strong links with academic Key Opinion Leaders around the world and supports clinical research in the field of neonatal intensive care.

Further information on Inspiration Healthcare Group plc can be seen at www.inspirationhealthcaregroup.plc.uk

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCDZGZLDFVGMZM

(END) Dow Jones Newswires

September 24, 2021 01:59 ET (05:59 GMT)